Evidenced-based medicine in glioma: molecular biology is only part of the story

The European Low-Grade Glioma Network

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E510-E510
JournalLancet Oncology
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 2017

Cite this

The European Low-Grade Glioma Network . / Evidenced-based medicine in glioma : molecular biology is only part of the story . In: Lancet Oncology. 2017 ; Vol. 18, No. 9. pp. E510-E510.
@article{82c031e49a044b72a923f28a38d4cbfa,
title = "Evidenced-based medicine in glioma: molecular biology is only part of the story",
author = "M Klein and {The European Low-Grade Glioma Network}",
year = "2017",
month = "9",
doi = "10.1016/S1470-2045(17)30510-7",
language = "English",
volume = "18",
pages = "E510--E510",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "9",

}

Evidenced-based medicine in glioma : molecular biology is only part of the story . / The European Low-Grade Glioma Network .

In: Lancet Oncology, Vol. 18, No. 9, 09.2017, p. E510-E510.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Evidenced-based medicine in glioma

T2 - molecular biology is only part of the story

AU - Klein, M

AU - The European Low-Grade Glioma Network

PY - 2017/9

Y1 - 2017/9

U2 - 10.1016/S1470-2045(17)30510-7

DO - 10.1016/S1470-2045(17)30510-7

M3 - Article

VL - 18

SP - E510-E510

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 9

ER -